Norges Bank Passage Bio, Inc. Transaction History

Norges Bank

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2023	BUY	$2.66 - $6.49 $102,144 - $249,216	38,400 New	38,400 $119,000
Q1 2022 May 09, 2022	SELL	$2.66 - $6.49 $178,220 - $434,830	-67,000 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$6.24 - $10.2 $418,080 - $683,400	67,000 New	67,000 $425,000
Q3 2021 Nov 14, 2022	BUY	$9.73 - $15.52 $1.79 Million - $2.86 Million	184,400 New	184,400 $1.84 Million
Q3 2021 Nov 05, 2021	SELL	$9.73 - $15.52 $1.08 Million - $1.72 Million	-111,076 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$12.44 - $19.45 $1.38 Million - $2.16 Million	111,076 New	111,076 $1.47 Million
Q2 2021 Aug 10, 2021	SELL	$12.44 - $19.45 $300,749 - $470,223	-24,176 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$16.24 - $29.83 $392,618 - $721,170	24,176 New	24,176 $423,000
Q1 2021 May 07, 2021	SELL	$16.24 - $29.83 $542,286 - $996,083	-33,392 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$14.28 - $29.73 $476,837 - $992,744	33,392 New	33,392 $854,000
Q3 2020 Nov 10, 2020	SELL	$12.39 - $26.15 $247,800 - $523,000	-20,000 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$14.59 - $36.07 $291,800 - $721,400	20,000 New	20,000 $547,000
Q2 2020 Aug 07, 2020	SELL	$14.59 - $36.07 $291,800 - $721,400	-20,000 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$8.86 - $22.2 $177,200 - $444,000	20,000 New	20,000 $315,000

38.7M

7.7K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $31M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.